Alice Assinger: Recruiting PhD Students for NET-IT Doctoral Program in Vienna
Alice Assinger, Professor at the Medical University of Vienna, shared on LinkedIn:
”We’re growing – and I’m excited to announce that we are recruiting 10 PhD students for our FWF-funded doctoral program NET-IT, exploring the interplay between vascular inflammation and thrombosis.
Apply now and be part of a supportive, ambitious, and highly collaborative environment, with the opportunity to shape your own project, develop independence, and contribute to meaningful science.
What we offer:
- A stimulating and international research environment in Vienna
- Strong mentorship and career development
- Projects at the forefront of cardiovascular and thrombo-inflammatory research
Application deadline: 26.04.2026, 23:55 CET
- Visit the online application portal
- Submit your application by the deadline
- Indicate your interest in our lab and your research aspirations
More information on the PhD program and available projects.
If you’re passionate about science and eager to make an impact, we would love to hear from you.
And if you know someone who might be a great fit, please share!”
Stay updated with Hemostasis Today.
-
Jul 8, 2026, 14:17Maha Othman: Advancing Thrombosis and Hemostasis Research at ISTH 2026
-
Jul 8, 2026, 14:07Zain Khalpey: Atrial Fibrillation as the Hidden Driver of Preventable Ischemic Stroke
-
Jul 8, 2026, 11:33Ifeanyichukwu Ifechidere: Haemophilia A and B – From First Diagnosis to the Era of Gene Therapy
-
Jul 8, 2026, 10:29Bringing Hemophilia Care Closer to Communities in Togo – WFH
-
Jul 8, 2026, 10:12Natasha Jolakoski: Completing Advanced Training in Thrombosis and Hemostasis
-
Jul 8, 2026, 09:58Rola Ghasoub: Early Intracranial Hemorrhage Remains the Main Barrier to Cure in Acute Promyelocytic Leukemia
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis